WCN25-4130 CLINICAL PRESENTATION OF THE FAMILIAL CASES OF ANCA-ASSOCIATED VASCULITIS: A SYSTEMATIC REVIEW

WCN25-4130 CLINICAL PRESENTATION OF THE FAMILIAL CASES OF ANCA-ASSOCIATED VASCULITIS: A SYSTEMATIC REVIEW

Saved in:

Bibliographic Details
Main Authors:	Nikolay Bulanov, Jinbo Zhao, Irina Smirnova, Natalya Vlasenko, Anna Stolyarevich, Sergey Moiseev, Daniel Munblit
Format:	Article
Language:	English
Published:	Elsevier 2025-02-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024924024677
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comorbid infections in patients with ANCA-associated systemic vasculitis: a prospective cohort study
by: M. A. Litvinova, et al.
Published: (2025-04-01)

WCN25-266 Performance of the different prediction tools for ANCA-associated glomerulonephritis: a retrospective cohort study
by: Nikolay Bulanov, et al.
Published: (2025-02-01)

RECURRENT ANCA-ASSOCIATED VASCULITIS AFTER KIDNEY ALLOTRANSPLANTATION
by: N. F. Frolova, et al.
Published: (2016-03-01)

THE ONSET OF ANCA-ASSOCIATED SYSTEMIC VASCULITIS MASKING RHEUMATOID ARTHRITIS
by: N. F. Frolova, et al.
Published: (2016-02-01)

PROBLEMS IN THE DIAGNOSIS AND TREATMENT OF ANCA-ASSOCIATED SYSTEMIC VASCULITIS: IN THE FOCUS OF ANCA-NEGATIVE PAUCI-IMMUNE GLOMERULONEPHRITIS
by: T. V. Beketova, et al.
Published: (2016-12-01)

Upper respiratory tract manifestations in patients with ANCA-associated vasculitides and their association with the presence and type of ANCA
by: I. G. Smirnova, et al.
Published: (2021-10-01)

Review of guideline for the management of ANCA-associated vasculitis, presented in 2021 by the American College of Rheumatology/Vasculitis Foundation
by: T. V. Beketova, et al.
Published: (2021-12-01)

WCN25-3205 CLINICAL PROFILE AND FOLLOW UP OF ANCA VASCULITIS IN CHILDREN AND THE FACTORS ASSOCIATED WITH ADVERSE LONG TERM RENAL OUTCOME
by: R.V. Deepthi, et al.
Published: (2025-02-01)

WCN25-2856 OVERLAP SYNDROME: A RARE TRIPLE-POSITIVE SYSTEMIC VASCULITIS: ANCA (MPO, PR3) AND ANTI-MBG
by: NEHED GHENAM, et al.
Published: (2025-02-01)

WCN25-1022 LONG-TERM KIDNEY FUNCTION BEYOND 12 MONTHS AND KIDNEY RELAPSE AFTER INITIATION OF TREATMENT FOR ANCA-ASSOCIATED VASCULITIS
by: Lisa Uchida, et al.
Published: (2025-02-01)

Case report: Testicular manifestation of ANCA vasculitis
by: Noah J. Sandel, et al.
Published: (2025-03-01)

Thrombosis risk factors in ANCA-associated vasculitis
by: E. N. Kharlamova, et al.
Published: (2023-04-01)

Hydralazine-Induced ANCA Vasculitis Presenting With Pericarditis: A Novel Case and Literature Review
by: Ahmed Sami Hammami, et al.
Published: (2025-01-01)

WCN24-395 AVACOPAN IN MPO-ANCA VASCULITIS: WHEN CORTICOSTEROIDS CAN NOT BE THE LONG TERM ANSWER
by: Sofia Sousa, et al.
Published: (2024-04-01)

WCN25-945 PROGNOSTIC OF THE PERSISTENCE OF HEMATURIA AND PROTEINURIA AFTER INDUCTION IN VASCULITIS ASSOCIATED WITH ANCA IN THE NEPHROLOGY SERVICE, HOSPITAL DE CLÍNICAS UNIVERSITARIO, BOLIVIA
by: Luis Alberto Céspedes Limachi, et al.
Published: (2025-02-01)

Comparison of different ANCA detection methods in a predominantly MPO-ANCA-associated vasculitis cohort
by: Yasuhiro Katsumata, et al.
Published: (2025-01-01)

Treatment With Avacopan in ANCA–Associated Vasculitis With Kidney Involvement
by: Duvuru Geetha, et al.
Published: (2025-08-01)

Endothelial dysfunction of vessels at ANCA-associated systemic vasculitis
by: L. V. Sedaia, et al.
Published: (2015-08-01)

The Utility of Bronchoscopy in Hydralazine-Induced ANCA-Associated Vasculitis
by: Atulya Aman Khosla, et al.
Published: (2023-01-01)

Burden of coronary artery calcification in ANCA-associated vasculitis
by: Claire Cook, et al.
Published: (2025-01-01)

A Case of Hydralazine-Induced ANCA Vasculitis/Lupus Overlap Syndrome Presenting as Persistent Bicytopenia
by: Madiha Naqsh Siddiqui, et al.
Published: (2025-01-01)

ANCA-associated vasculitis presenting with progressive binocular manifestations: a case report and literature review
by: Lei Xi, et al.
Published: (2024-12-01)

WCN24-283 CAN SERUM AND HISTOLOGIC BIOMARKERS PREDICT KIDNEY AND OVERALL SURVIVAL IN ANCA-ASSOCIATED VASCULITIS?
by: António Inácio, et al.
Published: (2024-04-01)

WCN24-974 P-ANCA VASCULITIS VS. LUPUS NEPHRITIS A POSSIBLE COEXISTENCE? CASE REPORT
by: Karen Kortright, et al.
Published: (2024-04-01)

WCN24-2308 WHAT TO EXPECT WHEN DIAGNOSING ANCA-ASSOCIATED VASCULITIS? A PORTUGUESE CENTER PERSPECTIVE AND EXPERIENCE
by: António Inácio, et al.
Published: (2024-04-01)

WCN24-1407 CLINICAL PANORAMA OF ANCA ASSOCIATED VASCULITIS IN A RURAL LOW-INCOME POPULATION OF LATIN AMERICA
by: PAULA VIOLETA RODRIGUEZ SEGURA, et al.
Published: (2024-04-01)

ANCA-Associated Vasculitis after Moderna COVID-19 Vaccination
by: Shiko Gen, et al.
Published: (2023-01-01)

Practical Management of ANCA-Associated Vasculitis: A Clinician’s Perspective
by: Hannah L. Stacey, et al.
Published: (2024-12-01)

Exploring ANCA Pathogenicity in Ulcerative Colitis: A Case Report Highlighting the Risk of Progression to ANCA-Associated Vasculitis
by: Abir Hamid, et al.
Published: (2025-05-01)

The plasma proteome reveals distinct signaling pathways associated with PR3-ANCA positive and MPO-ANCA positive vasculitis
by: Erik Hellbacher, et al.
Published: (2025-06-01)

ANCA Vasculitis and Hemophagocytic Lymphohistiocytosis following a Fecal Microbiota Transplant
by: Adam Amlani, et al.
Published: (2018-01-01)

“Fleshy” Skin Cellulitis: A Triggering Factor for ANCA Associated Vasculitis
by: Sim Chun Yang, et al.
Published: (2020-02-01)

Successful total hip arthroplasty in patients with anca-associated systemic vasculitis
by: T. V. Beketova, et al.
Published: (2019-11-01)

“Fleshy” Skin Cellulitis: A Triggering Factor for ANCA Associated Vasculitis
by: Sim Chun Yang, et al.
Published: (2020-02-01)

New ACR/EULAR 2022 classification criteria for ANCA-associated vasculitis
by: T. V. Beketova
Published: (2023-10-01)

Prospective study of complications and sequelae of glucocorticoid therapy in ANCA-associated vasculitis
by: Bernhard Hellmich, et al.
Published: (2024-02-01)

WCN25-3629 CLINICAL PROFILE, TREATMENT MODALITIES AND OUTCOME IN ANCA (ANTINEUTOPHILIC CYTOPLASMIC ANTIBODY) ASSOCIATED) VASCULITIS WITH KIDNEY INVOLVEMENT- A SINGLE CENTRE EXPERIENCE FROM SOUTH INDIA
by: Nividha Sharma, et al.
Published: (2025-02-01)

A Case Report Describing a Rare Presentation of Simultaneous Occurrence of MPO-ANCA-Associated Vasculitis and Rheumatoid Arthritis
by: Nathalie Foray, et al.
Published: (2016-01-01)

WCN25-3712 CRYOGLOBULINEMIC GLOMERULONEPHRITIS AND VASCULITIS IN THE SETTING OF SJOGREN'S SYNDROME
by: Preethi Subramanian, et al.
Published: (2025-02-01)

WCN25-637 QUALITY IMPROVEMENT PROJECT EXPLORING THE DIAGNOSTIC EXPERIENCES, PREFERENCES AROUND CARE AND IMPACT OF DISEASE ON PATIENTS WITH ANCA-ASSOCIATED VASCULITIS – FROM A UK BASED TERTIARY CENTRE
by: Richu Philip, et al.
Published: (2025-02-01)